Andrea Vilaplana Blanes I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors. Institutions of which they are part Research technician Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Andrea Vilaplana Blanes LinkedIn Twitter Orcid Email Institutions of which they are part Research technician Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors.
I studied Biochemistry and Biomedical Sciences degree at the University of Valencia between 2015 and 2019. I arrived in Barcelona in 2019 to start the Master in Translational Research at VHIR together with the Autonomous University of Barcelona. My professional experience is focused on childhood cancer research. In 2020 I started working as Data Manager / Data Entry in the Pediatric Oncology and Hematology Area of Vall d'Hebron Hospital. Currently, since March 2022, I am part of the Research Group on Childhood Cancer and Hematological Diseases at VHIR, developing research tasks as well as database and project management activities. My research activity is focused on the search for new biomarkers and molecular alterations in childhood tumors, especially in a specific subtype of solid tumor called neuroblastoma. Thanks to the incorporation to the group I am a part of numerous national and international projects and research organizations. I am sure that these will help to improve the quality of life and the chances of survival of our patients.
Projects Incorporación de terapias dirigidas e inmunoterapia para el tratamiento de niños y adolescentes con neuroblastoma en recaída mediante su caracterización genómica y el desarrollo del ensayo clínico aleatorizado fase 2 BEACON2. IP: Lucas Moreno Martín-Retortillo Collaborators: Andrea Vilaplana Blanes, Aroa Soriano Fernández, Jessica Camacho Soriano, Lorena Valero Arrese, Raquel Hladun Alvaro, Gabriela Guillén Burrieza Funding agency: Instituto de Salud Carlos III Funding: 240000 Reference: PI24/01576 Duration: 01/01/2025 - 31/12/2027 Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders IP: Lucas Moreno Martín-Retortillo Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 00638 Duration: 01/01/2022 - 30/06/2025 Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain IP: Lucas Moreno Martín-Retortillo Collaborators: Andrea Vilaplana Blanes, Aroa Soriano Fernández, Aroa Soriano Fernández, Margarita Ortega Blanco, Miguel Segura Ginard, Lorena Valero Arrese, Berta Campos Estela, Raquel Hladun Alvaro, Elena Antima Martinez Saez, Marta Sese Faustino, Estela Carrasco López, Gabriela Guillén Burrieza, Josep Roma Castanyer Funding agency: Instituto de Salud Carlos III Funding: 369260 Reference: PMP21/00073 Duration: 01/01/2022 - 30/06/2026 Next generation personalised medicine for childhood cancers IP: Lucas Moreno Martín-Retortillo Collaborators: Andrea Vilaplana Blanes, Aroa Soriano Fernández, Jessica Camacho Soriano, Lorena Valero Arrese, Raquel Hladun Alvaro, Next generation personalised medicine for childhood cancers, Gabriela Guillén Burrieza Funding agency: Instituto de Salud Carlos III Funding: 214170 Reference: PI21/01661 Duration: 01/01/2022 - 30/06/2026 Pagination Current page 1 Page 2 Next page › Last page »
